Showing results (191-200 of 242) with videos related to
Sort By:
Pageof 25
Archives of Gynecology and Obstetrics|February 1, 2018
Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?Hanifi Sahin, Mustafa Erkan Sari, Zeliha Firat Cuylan, et al.Gynecologic Oncology|November 23, 2020
Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: A nationwide, cohort study from TurkeyAli Ayhan, Murat Oz, Nazli Topfedaisi Ozkan, et al.Journal of Gynecologic Oncology|November 30, 2017
Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group studyAli Ayhan, Nazlı Topfedaisi Ozkan, Mustafa Erkan Sarı, et al.International Journal of Clinical Practice|May 7, 2021
Does hospitalisation of a patient in the intensive care unit cause anxiety and does restriction of visiting cause depression for the relatives of these patients during COVID-19 pandemic?Behiye Deniz Kosovali, Nevzat Mehmet Mutlu, Canan Cam Gonen, et al.Turkish Journal of Ophthalmology|February 26, 2021
Evaluation of the Cataract Surgery 2018 Survey in Terms of Achieving Refractive Cataract Surgery Targetsİzzet Can, Tamer Takmaz, Akif Özdamar, et al.American Journal of Human Genetics|December 27, 2011
Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndromeErsan Kalay, Orhan Sezgin, Vasant Chellappa, et al.International Journal of Clinical Oncology|November 9, 2014
Is mucinous adenocarcinoma of the endometrium a risk factor for lymph node involvement? A multicenter case-control studyKemal Gungorduk, Aykut Ozdemir, Ibrahim Egemen Ertas, et al.Journal of Clinical Medicine|June 26, 2026
Feasibility and Concordance of a Large Language Model (ChatGPT-5) as a Clinical Decision Support Tool in Gynecologic Oncology Tumor Boards: A Blinded, Multi-Observer StudyHatice Asoglu, Sevgul Kose, Oguzhan Kayim, et al.Journal of Ovarian Research|March 7, 2018
Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?Hanifi Sahin, Mehmet Mutlu Meydanli, Mustafa Erkan Sari, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.Pageof 25